Comparison Trial of White Light, Autofluorescence and Narrow Band Imaging Bronchoscopy (NWA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00548730|
Recruitment Status : Unknown
Verified January 2009 by Maimonides Medical Center.
Recruitment status was: Recruiting
First Posted : October 24, 2007
Last Update Posted : February 10, 2009
|First Submitted Date||October 22, 2007|
|First Posted Date||October 24, 2007|
|Last Update Posted Date||February 10, 2009|
|Study Start Date||October 2007|
|Primary Completion Date||Not Provided|
|Current Primary Outcome Measures
||Degree of correlation between three different bronchoscopic images [ Time Frame: One day ]|
|Original Primary Outcome Measures||Same as current|
|Change History||Complete list of historical versions of study NCT00548730 on ClinicalTrials.gov Archive Site|
|Current Secondary Outcome Measures
||Elimination of false positives and negative bronchoscopic examinations for neoplasia [ Time Frame: One day ]|
|Original Secondary Outcome Measures||Same as current|
|Current Other Outcome Measures||Not Provided|
|Original Other Outcome Measures||Not Provided|
|Brief Title||Comparison Trial of White Light, Autofluorescence and Narrow Band Imaging Bronchoscopy|
|Official Title||A Clinical Comparison Trial of White Light Bronchoscopy, Autofluorescence Bronchoscopy and Narrow Band Imaged Bronchoscopy|
|Brief Summary||The purpose of the study is to compare the three methods of bronchoscopic imaging to determine what combination is optimum to identify neoplastic mucosal abnormalities. The ability to decrease the rate of false-positive and false negative findings of bronchoscopy also will be studied for each spectroscopic technique separately and for their combination.|
Patients with known or suspected malignancies of the lung and with a medical indication for a bronchoscopy will be invited to participate in the study. All patients must be over 18 years old and must sign informed consent. The endoscopic examination of the bronchial tree will be performed using a commercially available flexible fluorescence bronchoscope (11004BI; Karl Storz; Culver City, CA) and the flexible white light video-bronchoscope (BF-T180; Olympus; Center Valley, PA).
Images obtained will be photographed using both video recordings and parallel images of white light and imaged bronchoscopy. These digital images will be electronically stored and evaluated at a later time. Biopsies will be obtained of all suspected abnormalities. These will be correlated with the images.
Images will be identified as normal, suspect or abnormal based upon each modality independently, paired with the spectral image and all three combined. The control will be an area considered normal by all modes of bronchoscopy. Images will be graded at the time of bronchoscopy. Later, all images will be graded in a blind fashion by two independent bronchoscopists. Standard statistical analysis using paired Student's t test will be applied. We anticipate that the combination of one or more imaged bronchoscopy techniques will increase accuracy by 25%. Power calculation to detect such a difference will require 140 abnormal specimens. If 50% of patients examined have an abnormality, the study population will need to be around 300 patients.
Histopathology reports will be obtained on all specimens. Abnormal results will be discussed with the individual patient and appropriate procedures will be performed based upon best medical practices. These procedures and patient follow-up are beyond the scope of the study.
|Study Design||Observational Model: Cohort
Time Perspective: Prospective
|Target Follow-Up Duration||Not Provided|
|Biospecimen||Retention: Samples Without DNA
Endobronchial biopsies of normal and abnormal mucosa for histopathology
|Sampling Method||Non-Probability Sample|
|Study Population||Any patient with known or suspected malignancies of the lung and with a medical indication for a bronchoscopy|
The endoscopic examination of the bronchial tree will be performed using a commercially available flexible fluorescence bronchoscope and the flexible white light video-bronchoscope. Biopsies are taken of a normal region and all abnormal regions.
Patients with known or suspected malignancies of the lung and with a medical indication for a bronchoscopy
Intervention: Procedure: Bronchoscopy
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Recruitment Status||Unknown status|
|Original Estimated Enrollment||Same as current|
|Estimated Study Completion Date||December 2010|
|Primary Completion Date||Not Provided|
|Ages||18 Years and older (Adult, Senior)|
|Accepts Healthy Volunteers||No|
|Contacts||Contact information is only displayed when the study is recruiting subjects|
|Listed Location Countries||United States|
|Removed Location Countries|
|Other Study ID Numbers||MMC07/06VA14|
|Has Data Monitoring Committee||No|
|U.S. FDA-regulated Product||Not Provided|
|IPD Sharing Statement||Not Provided|
|Responsible Party||Joseph LoCicero, III, MD, Maimonides Medical Center|
|Study Sponsor||Maimonides Medical Center|
|PRS Account||Maimonides Medical Center|
|Verification Date||January 2009|